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ORIGINAL ARTICLE / ÖZGÜN ARAŞTIRMA
Comparing efficacy of preemptively used lornoxicam and tramadol for 
postoperative pain in patients underwent laparoscopic cholecystectomy
Laparoskopik kolesistektomi uygulanan hastalarda, ameliyat öncesi uygulanan 
lornoksikam ve tramadol’un postoperatif ağrı üzerine olan etkilerinin karşılaştırılması
Pakize Kırdemir1, Anıl Marşan2
ABSTRACT
Objectives: The management of postoperative pain is 
an  important  problem  in Anesthesiology.  This  random-
ized double-blind study compared the analgesic efficacy 
of preemptively used lornoxicam and tramadol in patients 
underwent laparoscopic cholecystectomy.
Methods: A total of 76 patients were randomly divided into 
four groups. All patients received tablets 4 hours before 
the operation. Preemptively Group PL received 4 mg lor-
noxicam, Group PT received 50 mg tramadol and Group 
L and T received placebo. After the operation Group PL 
received 0.8 mg/h infusion and 1 mg bolus lornoxicam; 
Group L 1.6 mg loading, 0.8 mg/h infusion and 1 mg bolus 
lornoxicam; Group PT 5 mg/h infusion and 10 mg bolus 
tramadol; Group T 20 mg loading, 5 mg/h infusion and 10 
mg bolus tramadol for 24 hours. Pain intensity and pain 
relief at 0, 1st, 2nd,3rd, 6th,10th, 24th hours and overall as-
sessment of pain relief was done at 24th hour.
Results:  Demographic  features,  operation  time,  heart 
rate and mean arterial blood pressure values were not 
different between four groups. Both Group PL and PT 
had lower pain intensity and higher pain relief values than 
Group L and T. Group PL and PT had lower total drug 
consumption and higher pain relief. Overall assessment 
of pain relief was highest in Group PL. Pain intensity was 
highest in Group T and lowest in Group PL at all time 
points.
Conclusion:  Onset  of  analgesia  with  lornoxicam  was 
faster and greater patient-controlled analgesia (PCA) de-
mand was observed with tramadol. Postoperative pain re-
lief was similar with lornoxicam and tramadol administrat-
ed by PCA. This study suggests that preemptive admin-
istration of lornoksikam and tramadol may result in more 
postoperative pain relief. J Clin Exp Invest 2010; 1(1): 1-6
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ÖZET
Amaç: Postoperatif ağrı, akut ağrının en sık nedenlerin-
den biridir. Postoperatif ağrı tedavisinin klasik şekli pa-
renteral opioid uygulamasıdır. Bu randomize çift-kör ça-
lışmada preemptif uygulanan lornoksikam ve tramadolün 
analjeziklerin etkinliklerinin karşılaştırılması amaçlandı.
Hastalar ve Yöntem: Toplam 76 hasta rastgele dört gru-
ba ayrıldı. Tüm hastalar operasyondan 4 saat öncesi tab-
let aldılar. Grup PL preemptif olarak 4 mg lornoksikam, 
Grup PT 50mg tramadol alırken, Grup L ve T ise plasebo 
tablet aldılar. Operasyon sonunda Grup PL’ye 8 mg/saat 
infüzyon ve 1 mg bolus lornoksikam; Grup L’ye 1.6mg 
yükleme, 8 mg/saat infüzyon ve 1 mg bolus lornoksikam; 
Grup PT’ye 5 mg/saat infüzyon ve 10 mg bolus tramadol; 
Grup T’ye 20 mg yükleme, 5 mg/saat infüzyon ve 10 mg 
bolus tramadol hasta kontrollü (PCA) ile 24 saat boyunca 
uygulandı. Ağrı şiddeti 0,1., 2., 3., 6., 10., 24. saatlerde 
kaydedildi ve 24 saat sonunda genel ağrı iyileşmesi de-
ğerlendirildi.
Bulgular:  Gruplar  arasında  demografik  bulgular,  ope-
rasyon süresi, kalp hızı ve ortalama kan basınç değerleri 
bakımından anlamlı fark gözlenmedi. Grup PL ve PT de 
Grup L ve T ye göre daha düşük ağrı şiddeti ve daha hızlı 
ağrı iyileşmesi görüldü. Grup PL ve PT’de daha az total 
analjezik tüketimi ve daha yüksek ağrı tedavisi memnuni-
yeti bulundu. Tüm gruplar birbirleriyle karşılaştırıldığında, 
24 saatlik ağrı tedavisi en iyi Grup PL’de bulundu. Ağrı 
şiddeti tüm zamanlarda Grup T’de en yüksek, Grup PL’de 
ise en düşük bulundu. 
Sonuç: Analjezi etkisi lornoksikam grubunda daha önce 
başlarken, ilaç ihtiyacı tramadol gruplarında daha fazla 
idi. Cerrahi girişim sonunda PCA kullanımı ile benzer ağrı 
iyileşmesi görüldü. Bu çalışma postoperatif ağrı tedavi-
sinde analjeziklerin preemptif uygulanmasının daha fazla 
analjezi sağlayabileceğini düşündürmektedir. Klin Den Ar 
Derg 2010; 1(1): 1-6
Anahtar kelimeler: Preempetif analjezi, lornoksikam, tra-
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INTRODUCTION
After surgery, severe pain is experienced by 50% 
-70%  of  patients  postoperatively,  while  a  further 
20%-40% of patients experience moderate pain1.
Postoperative  pain  not  only  causes  consider-
able distress to the patient, it also contributes to pro-
longed recovery time and may adversely affect pa-
tient outcome2. Despite well known disadvantages 
including respiratory depression and hypotension, 
opioid analgesics are the traditional first-line treat-
ment in postoperative pain3. Although opioids are 
effective analgesic drugs with no ceiling in their an-
algesic effect, their efficacy is often limited by their 
tolerability profile, therefore inadequate postopera-
tive analgesia has been a problem for several de-
cades4. Nonsteroid anti-inflamatuar drugs (NSAID) 
provide effective analgesia in patients with acute 
pain after surgery, either as a substitute or as an ad-
junct to opioid analgesia4,5. The major advantage of 
NSAIDs is relatively well tolerability in selected 
patients for short-term postoperative analgesia6. 
Tramadol is centrally acting opioid analgesic 
and provides effective postoperative pain relief es-
pecially for abdominal, gynecological and orthope-
dic procedures7,8. On the basis of its potency, trama-
dol has comparatively few disadvantages associated 
with other opiates, such as cardiovascular reactions, 
respiratory depression and physical dependency9. 
Injectable NSAID have recently become recog-
nized as useful agents in the treatment of postopera-
tive pain. Short usage effectiveness provides alter-
native to morphine4. Lornoxicam is a new NSAID 
belonging to enolic acid chemical class. Its analge-
sic potency in animal pain models exceeds that of 
tenoxicam and piroxicam by approximately 12- and 
3- fold respectively, and that of indomethacin and 
diclofenac by 4- and 6-fold, respectively10. Effective 
preemptive treatment of postoperative pain has been 
one of the main goals of clinicians and researchers. 
For this reason, we decide to give lornoxicam and 
tramadol preemptively to see if we could be able to 
reduce postoperative analgesic need and have good 
analgesia.
This study aimed to compare efficacy of pre-
emptively  used  tramadol  and  lornoxicam  for  the 
postoperative pain relief in patients underwent lap-
aroscopic cholecystectomy.
PATIENTS AND METHODS
After the approval of the Ethical Committee and ob-
taining the written consents, we performed a dou-
ble-blind randomized study on 76 ASA I-II patients 
aged between 18 and 65 undergoing laparoscopic 
cholosystectomy. The patients and the data collec-
tors were blinded to the treatment regimen and had 
no Access to the anesthesia record. Patients sensitive 
to NSAID, gastric ulcer complains last 6 months, 
coagulopaty, abnormal biochemistry results, using 
drugs interaction with tramadol or NSAID, receiv-
ing cytotoxic agents and alcohol or drug addict pa-
tients were excluded from the study. 
Preemptively, patients were instructed on the use of 
the 5-point verbal rating scale (5-VRS) for pain se-
verity before the operation. Scoring was determined 
as,  0=  no  pain,  1=mild  pain,  2=  tolerable  pain, 
3=severe and 4=pain resist. Pain severity recorded 
postoperative 0, 1st, 2nd, 3rd, 6th, 10th and 24th hours by 
using 5-VRS. Patients satisfaction were evaluated 
by the help of linear Pain Relief Scala (pain …-… 
no pain) as it was easy for the patients to understand 
and give an answer to the questions: 1= excellent 
(no pain) 2= very good (mild pain), 3=good (toler-
able pain), 4= fair (slight decrease in pain) and 5= 
bad (pain resist).
Seventysix patients were randomized into four 
groups. Patients were studied after an eight hours 
period of fast. No premedication were given. Con-
trol haemodynamic parameters of the patients were 
recorded after their arrival to the operating room. 
Heart rate (HR) and noninvazive mean arterial pres-
sure (MAP) were recorded every 15 minutes during 
the operation. 
All patients were given tablets 30 minutes be-
fore the operation. Group PL received 4 mg lornoxi-
cam, Group PT received 50 mg tramadol and Group 
L and T received placebo tablets orally. Group Pre-
emptive lornoxicam (PL, n=20) received 4mg lor-
noxicam, Group Preemptive Tramadol (PT, n=18) 
received 50 mg tramadol and Group Lornoxicam 
(L, n=20) and Group Tramadol (T, n=18) received 
placebo. Anesthesia was induced in all groups with 
thiopental 4 mg/kg intravenously (IV) and vecuro-
nium 0.1 mg/kg IV. Anesthesia maintenance was 
achieved with isoflurane 1-1.5%, O2 / N2O 50%, 
and maintenance of muscle relaxation was provided 
with 0.01 mg/kg vecuronium. After the operation Kırdemir et al. Preemptive lornoxicam and tramadol for postoperative pain 3
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Group PL received 0.8 mg/h infusion and 1 mg bo-
lus lornoxicam; Group L 1.6 mg loading, 0.8 mg/h 
infusion and 1 mg bolus lornoxicam; Group PT 5 
mg/h infusion and 10 mg bolus tramadol; Group T 
20 mg loading, 5 mg/h infusion and 10 mg bolus 
tramadol IV PCA for 24 hours. At end of the 24th 
hour patients’ satisfaction, total drug demand and 
side effects were also recorded. All the data were 
evaluated by using Chi-square and t-tests.
RESULTS
According  demographical  data,  operation  period, 
HR  and  MAP  all  groups  were  similar  and  there 
were no significant differences between the groups 
(p>0.05) (Table 1). 
Groups preemptively received lornoxicam and 
tramadol (Group PL and PT) had low pain inten-
sity and high pain relief when compared with other 
groups and these differences were statistically sig-
nificant (p<0.05) (Table 2). 
Table 1. Patients’ characteristics (mean±SD)
Group PL 
(n=20)
Group L
(n=20)
Group PT
(n=18)
Group T
(n=18)
Gender (M/F) 12/8 16/4 12/6 8/10
Age (year) 38±13.7 36.3±13.1 38.2±14.4 47.3±13.5
Weight (kg) 71.9±8.8 67.1±4.1 69.4±8.9 67.6±9.1
Height (cm) 168.6±10.3 165.8±7.9 166.1±10.6 162.9±6.9
Op. period (min) 71.3±17.5 72.3±30.3 80±18.3 76.4±45
Group PL:preemptive lornoxicam, Group L:lornoxicam, Group PT:preemptive tramadol, Group T:tramadol, 
M/F: Male/Female, kg:kilogram, cm:centimetre, min.: minute
Table 2. Visual analogue scores (mean±SD)
Postoperative Group PL Group L Group PT Group T
0 1.13±0.36∗ 1.6±0.9 1.2±0.4 2.4±0.9
1st  hour 0.38±0.7∗ 0.7±0.6 1 1.9±0.9
2nd  hour 0.13±0.36∗ 0.3±0.5 0.9±0.3 1.4±0.5
3rd  hour 0.13±0.36∗ 0.3±0.5 0.4±0.5  0.7±0.8
6th  hour 0 0 0 0.3±0.5
10th  hour 0 0 0 0.3±0.5
24th  hour 0 0 0 0.3±0.5
Grup PL: preemptive lornoxicam, Grup L: lornoxicam, Grup PT: preemptive tramadol, Grup T: tramadol 
∗p<0.05 between the groups
In Group L postoperative values at 1, 2 and 3rd 
hours were lower than Group PT but were not sta-
tistically significant.
Also in Group PL and Group PT total analgesic 
demand were low (p<0.05) and patients’ satisfac-
tion were significantly high (p<0.05) (Table 3).
Patients’ satisfactions were in Group PL 85 % 
excellent and very good, in Group PT 78.2%, in 
Group L 70% and Group T 66.5%. Regarding these 
results groups receiving preempetively lornoxicam 
had the highest values of patients’satisfaction and 
these results were significant comparing with other 
groups (p<0.05) (Table 4). 
Pain intensity was highest in Group T and low-
est in Group PL in all times.Kırdemir et al. Preemptive lornoxicam and tramadol for postoperative pain 4
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Table 3. Total analgesic demand (mg)
Group PL Group L Group PT Group T
Total analgesic
demand (mg) 17.1±4 18..9±5.6 229.1±54.7 275.8±64.6
Group PL: preemptive lornoxicam, Group L: lornoxicam, Group PT: preemptive tramadol, Group T: trama-
dol, mg: miligram
morphine in 150 patients experiencing moderate or 
severe pain. The results of that study showed that 
whereas the analgesic potency of tramadol and mor-
phine were similar, tramadol has markedly less clin-
ically significant respiratory depressive effects than 
morphine7. Perhaps this is because the analgesic ef-
fects of tramadol are mediated by non-opioid recep-
tor mechanisms of action. Karslı et al., compared 
preemptive tramadol 50 mg and meperidine 50 mg 
IV were found to be effective on postoperative pain 
and also total analgesic consumption for 24 hours 
was lower according placebo group13. Also another 
study designed by Yeğin et al. for post-thoracotomy 
pain relief. They found that intrapleural and inter-
costal analgesia were more effective than IV pre-
emptive tramadol14. In that study, administration of 
additional local anesthetic via intrapleural catheter 
resulted in more effective analgesia.
Unlike opioids, NSAIDs do not cause respira-
tory depression, dependency, sedation, reduced gut 
motility or significant haemodynamic effects, and 
this has undoubtedly aided their rise in popularity. 
Numbers of NSAIDs have been shown to produce 
analgesia equivalent or superior to that gained with 
opioids in a variety of postsurgical setting15. Lor-
noxicam is rapidly eliminated and its plasma half-
life after the intravenous dose is 3.5 to 4.5 hours; 
this suggests a suitably acute action for use in post-
operative pain control16. In the studies done by Nor-
holt, Rosenow and Ilias, lornoxicam has been shown 
to be as affective as morphine, meperidine and tra-
madol for the treatment of postoperative pain15,17,18. 
Also Berry, Caruso and Bernstein showed in their 
studies  that  lornoxicam  has  demostrated  clinical 
efficacy in relieving chronic pain associated with 
osteoartritis,  rheumatoid  artritis  and  ankylosing 
spondylitis19,20,21. 
Staunstrup and et al. compared the analgesic ef-
fects of IM lornoxicam and tramadol for arthroscpic 
surgery and they showed that IM lornoxicam offers 
Tablo 4. Patients’ satisfaction scores, n (%)
Grup PL 
(n=20)
Grup L
(n=20)
Grup PT
(n=18)
Grup T 
(n=18)
Excellent 12 (60.0) 8 (40.0) 10 (56.0) 7 
(38.8)
Very good 5 (25.0) 6 (30.0) 4 (22.2) 5 
(27.7)
Good 2 (10.0) 4 (20.0) 3 (16.6) 3 
(16.6)
Fair 1 (5.0) 2 (10.0) 1 (5.5) 3 
(16.6)
Bad - - - -
Group PL: preemptive lornoxicam, Group L: lornoxi-
cam, Group PT: preemptive tramadol, Group T: tra-
madol 
DISCUSSION
Postoperative pain is the most common form of acute 
pain and affects the majority of patients undergoing 
surgery. The provision of adequate analgesia is not 
only important from a humanitarian perspective but 
also been shown to improve postoperative recov-
ery and outcome. The most commonly used agents 
for the control of postoperative pain are parenteral 
opioid analgesics. Although these agents are potent 
and extremely effective, fears about addiction and 
respiratory and cardiovascular depression can result 
in a reluctance to administer sufficient medication 
and may lead to inadequate management of post-
operative  pain11.  This  clinical  research  has  dem-
onstrated satisfactory postoperative analgesia and 
lower  analgesic  demand  when  preemptive  drugs 
were administrated. According to these results, we 
used lornoxicam and tramadol preemptively so as to 
have good analgesia with lower analgesic demand. 
Preemptive analgesia prevents secondary hyperal-
gesia, which supports a role for central sensitization 
in the generation of postoperative pain12.
Tramadol; fulfills the requirements of an an-
algesic  for  treatment  of  moderate  postoperative 
pain such as abdominal, gynecological and ortho-
pedic surgery7. Houmes et al. designed a study to 
investigate the efficacy of intravenous tramadol and Kırdemir et al. Preemptive lornoxicam and tramadol for postoperative pain 5
J Clin Exp Invest   www.clinexpinvest.org   Vol 1, No 1, April 2010
a useful alternative to tramadol for the treatment of 
moderate to severe postoperative pain11.
İlias et al. conducted multiple-dose study, 80 pa-
tients with pain after gynecologic surgery received 
IV 4 mg or 8 mg lornoxicam and 50 mg tramadol. 
They found out that 8 mg lornoxicam was well tol-
erated and more effective than others18.
Preemptive  analgesia  is  an,  antinociseptive 
treatment  that  prevents  establishment  of  altered 
processing of afferent input which amplifies post-
operative pain22. It is important to start before inci-
sion and cover both the period of surgery and initial 
postoperative period23.
Patient  control  analgesia  provides  effective 
pain treatment, adjusts the dose according to per-
sonal need and keeps plasma analgesic levels at a 
constant level24.
There are several studies preemptively done. 
In his study Wang had 3 groups receiving PCIA 
(Patient control intravenous analgesia) Morphine, 
Tramadol and Tramadol+Lornoxicam respectively. 
Tramadol+Lornoxicam had the same good analgesia 
and less immunity depression than other groups25. 
Karaca et al. administered preemptively Tramadol 
and Lornoxicam via PCA pump for gynecological 
surgery. Adequate analgesia was achieved in both 
groups but tramadol has beter analgesia than lor-
noxicam during the first 12 hours postoperatively26. 
Kemal et al.27 have given preemptively Tramadol, 
Tramadol+Metamizol  and  Tramadol+Lornoxicam 
and found that tramadol combinations had efficient 
postoperative analgesia with less side effects. Ölmez 
et al.28 have compared efficacy of Tamadol and Lor-
noxicam during transrectal ultrasound guided biop-
sy of the prostate. Patients received 100 mg Trama-
dol and 8 mg Lornoxicam IM 30 minutes prior the 
procedure. Both had lower VAS scores compared to 
the control group but pain and discomfort were least 
in the Tramadol group28. In their study Karaman 
et al. aimed to examine the effect of Lornoxicam 
before and after skin incision. Preemptively given 
Lornoxicam improved the quality of analgesia and 
leaded to reduced consumption of postoperative an-
algesic29. According all these studies we saw that 
preemptively given analgesics provided good anal-
gesia than postoperative administreted analgesics25-
29. Combinations had always better results25,27. Some 
of the authors found tramadol more effective than 
lornoxicam26,28.
Although preemptively given, lornoxicam and 
tramadol  both  improved  postoperative  analgesia, 
while lornoxicam group had statiscally significant 
lower VAS values than the other groups. These re-
sults show similarity to the study done by Rosenow 
et al30. But in present study we did not see any side 
effects. The administration of preemptive lornoxi-
cam  improved  postoperative  analgesia,  resulting 
analgesic consumption with highest patients’ satis-
faction.
In conclusion, the results of this study suggest-
ed that both drugs were effective in the treatment 
of moderate postoperative pain and well tolerated 
when administered preemptively.
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